Overview of patients investigated in this study. Pre- and postoperative visual acuity was measured in all patients. Available VEP results are shown. Evaluation mode, duration of symptoms, and determination of diabetic stage are displayed for every individual
| Patient No | Visual acuity pre/post | VEP latency (ms) pre/postop | VEP amplitude (μV) pre/postop | Duration of traction (years) | Evaluation type | Diabetes type |
|---|---|---|---|---|---|---|
| 1 | 0.02/0.1 | 84/88 | 8.6/6.6 | 1 | prospective | II |
| 2 | 0.3/0.5 | 168/130 | 3.7/3.9 | 1 | prospective | II |
| 3 | 0.02/0.1 | 86/82 | 3.9/2.9 | 5 | prospective | II |
| 4 | 0.02/0.05 | 85/78 | 2.8/14.8 | 1 | prospective | II |
| 5 | 0.5/0.5 | 154/152 | 4.3/6.4 | 1 | prospective | I |
| 6 | 0.05/0.1 | 118/230 | 2.3/12.1 | 1.5 | prospective | II |
| 7 | 0.02/0.4 | 142/118 | 4.5/3.3 | 0.5 | prospective | II |
| 8 | 0.02/0.2 | NA/142 | NA/3.9 | 2 | prospective | II |
| 9 | 0.08/0.02 | NA/138 | NA/3.9 | 10 | retrospective | I |
| 10 | 0.4/0.5 | NA | NA | 1 | retrospective | II |
| 11 | 0.2/0.3 | NA | NA | 4 | retrospective | II |
| 12 | 0.02/0.5 | NA | NA | 2 | retrospective | I |
| 13 | 0.3/0.4 | NA | NA | 1.5 | retrospective | I |
| 14 | 0.2/0.4 | 130/80 | 5.1/5.25 | 2 | prospective | II |
| 15 | 0.1/0.3 | 124/124 | 4.7/6.0 | 3.5 | prospective | I |
| 16 | 0.05/0.3 | 152/106 | 2.3/4.5 | 6 | prospective | I |
| 17 | 0.02/0.4 | 142/135 | 3.9/5.8 | 2.5 | prospective | II |
NA = data not available.